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a b s t r a c t
Background: Human sapovirus (SaV) is a causative agent of acute gastroenteritis. Recently, SaV detection
has been increasing worldwide due to the emerging SaV genotype I.2. However, SaV infection has not
been reported in the Philippines.
Objectives: To evaluate the prevalence and genetic diversity of SaV in hospitalized children aged less than
5 years with acute gastroenteritis.
Study design: Stool samples were collected from children with acute gastroenteritis at three hospitals
in the Philippines from June 2012 to August 2013. SaV was detected by reverse transcription real-
time PCR, and the polymerase and capsid gene sequences were analyzed. Full genome sequencing and
recombination analysis were performed on possible recombinant viruses.
Results: SaV was detected in 7.0% of the tested stool samples (29/417). In 10 SaV-positive cases, other
viruseswere also detected, including rotavirus (n=6), norovirus (n=2), andhuman astrovirus (n=2). Four
known SaV genotypes (GI.1 [7], GI.2 [2], GII.1 [12], and GV [2]) and one novel recombinant (n=3) were
identiﬁed by polymerase and capsid gene sequence analysis. Full genome sequencing revealed that the
5′ nontranslated region (NTR) and nonstructural protein region of the novel recombinant were closely
related to the GII.1 Bristol/98/UK variant, whereas the structural protein region and 3′ NTR were closely
related to the GII.4 Kumamoto6/Mar2003/JPN variant.
Discussionandconclusions:SaVwas regularlydetected inhospitalizedchildrendue toacutegastroenteritis
during the studyperiod. Anovel recombinant, SaVGII.1/GII.4,was identiﬁed in three cases at twodifferent
study sites.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Background
Acute gastroenteritis remains an important cause of childhood
morbidity and mortality in developing countries. Sapovirus (SaV),
ﬁrst reported in the late 1970s, is a causative agent of acute gas-
troenteritis [1]. Although SaV has been reported to cause milder
illness than rotavirus and norovirus [2], severe SaV cases and SaV-
Abbreviations: SaV, human sapovirus; ORF, open reading frame; G, genogroup;
PCR, polymerase chain reaction; nt, nucleotide; NTR, nontranslated region.
∗ Corresponding author. Tel.: +81 22 717 8210; fax: +81 22 717 8212.
E-mail address: msaitop@med.tohoku.ac.jp (M. Saito).
associated outbreaks in different age groups have been reported,
which suggests its importance [3,4], However, the epidemiol-
ogy of SaV remains poorly understood, particularly in developing
countries due to the need for expensive molecular methods for
diagnosis.
SaV belongs to the Caliciviridae family and it infects both
humans and animals [5]. Human SaV can be divided into four
genogroups (GI, GII, GIV, and GV) and further subdivided into 17
genotypes with 20.1% or more nucleotide variation in the cap-
sid gene [6]. The genomes of SaV GI, GIV, and GV contain three
open reading frames (ORFs), whereas, that of SaV GII has two ORFs.
ORF1 encodes the nonstructural proteins and a major capsid pro-
tein, and ORF2 and ORF3 encode proteins whose functions are still
http://dx.doi.org/10.1016/j.jcv.2015.05.001
1386-6532/© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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Table 1
Primers used in this study to detect and characterize sapovirus.
Use Primer/probe Nucleotide sequence (5′#65#) Position Source
Real-time PCR Sav1F TTGGCCCTCGCCACCTAC 5077–5094a [19]
Sav5F TTTGAACAAGCTGTGGCATGCTAC 5112–5135a
Sav124F GAYCASGCTCTCGCYACCTAC 5074–5094a
Sav1245R CCCTCCATYTCAAACACTA 5159–5177a
Sav124 probe VIC-CCRCCTATRAACCA-MGB 5101–5117a
Sav5 probe VIC-TGCCACCAATGTACCA-MGB 5142–5157b
Capsid genotyping SV-F13 GAYYWGGCYCTCGCYACCTAC 5074–5094a [21]
SV-F14 GAACAAGCTGTGGCATGCTAC 5074–5094a
SV-R13 GGTGANAYNCCATTKTCCAT 5876–5861a
SV-R14 GGTGAGMMYCCATTCTCCAT 5876–5861a
SV-F22 SMWAWTAGTGTTTGARATG 5154–5172a
SV-R2 GWGGGRTCAACMCCWGGTGG 5591–5572a
Polymerase genotyping SaV4579a CCATCTGGGATGCCATTYAC 4525–4544a Current study
SaV4579b CCNTCDGGNATGCCNTTYAC 4525–4544a
SaV1245R CCCTCCATYTCAAACACTA 5159–5177a [19]
Ampliﬁcation/sequencing
of whole genome
TX30SXN GACTAGTTCTAGATCGCGAGCGGCCGCCCT29 Oligo dT Current study
1F GTGATTGGTTRGTATGGCTTC 1–21c
600R TTTACCACYTGTCGCCACAT 581–600c
401F TACTCCACCGATTCGCTC 401–418c
2922R CGCCACTCATCRTACTC 2906–2922c
2709F ATCACCCGCAACATGAC 2693–2709c
2099R TAGCWGCCATGTAKGATTTC 2080–2099c
3491F GCATCATYAATGGTTACCC 3489–3507c
4292R ACCTGGCAACTRTCCATGTT 4292–4311c
5744F CARCCVYTNATCAACCCSTT 5750–5769c
6650F ATGGCAGTGTTCAATGTGGA 6650–6669c
a Position in complete sapovirus GI genogroup sequence (Manchester, accession no. X86560).
b Position in complete genome of sapovirus GV genogroup (NongKhai-24/Thailand, accession no. AY646856).
c Position in complete genome of GII genogroup (Bristol/98/UK, accession no. AJ249939).
unknown [7]. The capsid protein is thought to be cleaved from the
ORF1 polyprotein by a protease and/or directly translated from
subgenomic RNA [8,9]. Although several genotypes were identi-
ﬁed in a longitudinal surveillance study in Japanduring 2003–2009,
SaV GI.1 was the predominant genotype, except in the winters of
2004–2005 and 2007–2008 [10]. SaV GI.1 was also the most fre-
quentlydetectedgenotype in sporadic gastroenteritis cases [11,12].
Since 2007, several SaV GI.2 outbreaks have been reported in
Europe, Asia, and North America [4,13], and GI.2 is regarded as an
emerging genotype [4]. In the SaV genome, recombination typi-
cally occurs within ORF1 at the junction between the polymerase
and capsid genes [14,15], which can generate antigenically distinct
strains [16]. Some of these recombinants have caused outbreaks in
various countries [13,17].
2. Objectives
To deﬁne the prevalence and genetic characteristics of SaV
among hospitalized children with acute gastroenteritis in the
Philippines from June 2012 to August 2013.
3. Study design
3.1. Study sites and sample collection
We conducted a prospective etiological study of hospitalized
children aged less than5years due to acute gastroenteritis between
June 2012 and August 2013 at three hospitals (Supplementary Fig.
1): EasternVisayasRegionalMedicalCenter (EVRMC), TaclobanCity
on Leyte Island; Ospital ng Palawan (ONP), Puerto Princesa City on
Palawan Island; and Philippine Children’s Medical Center (PCMC),
Metro Manila. Informed consent was obtained from the parents or
legal guardians of the study children before stool sampling. The age
(date of birth), gender, and history of rotavirus vaccination of the
participants were recorded. Stool specimens were collected within
72h of illness onset and were transported at 4 ◦C to the Research
Institute for Tropical Medicine (RITM) and then stored at −80 ◦C.
Supplementrymaterial related to this article found, in theonline
version, at http://dx.doi.org/10.1016/j.jcv.2015.05.001
3.2. Detection of gastroenteric viruses using reverse transcription
PCR or real-time PCR
Viral nucleic acid was extracted from 20% clariﬁed stool sus-
pensions prepared in phosphate-buffered saline (PBS) using the
QIAamp MinElute Virus Spin Kit (Qiagen, Hilden, Germany).
For denaturation of double-stranded RNA of rotavirus, 0.5L
(0.3mg/mL) of random primers (Life Technologies, Carlsbad, CA,
USA), 0.5L of deoxynucleotide triphosphates (10mM, Life Tech-
nologies), and 4.25L of the extracted viral RNA were heated at
98 ◦C for 5min, followed by cooling on ice for 2min. Then, 4.75L
of the RT mixture, which contained 2L of 5× First-Strand buffer
(Life Technologies), 0.5L of dithiothreitol (0.1M, Life Technolo-
gies), 0.25L of RNaseOUT (40U/L, Life Technologies), 0.25L
of SuperScript III reverse transcriptase (200U/L, Life Technolo-
gies), and 1.75L of RNase free water was added. The mixture was
incubated at 25 ◦C for 5min, and at 50 ◦C for 60min, and then the
enzyme was inactivated by incubation at 70 ◦C for 15min.
Sampleswere screened for SaV and human astrovirus by duplex
real-time PCR using described primers and TaqMan probes [18,19].
The duplex real-time PCR was performed in an ABI 7500 Fast Real-
Time PCR system with TaqMan Fast Advanced master mix (Life
Technologies). The detection limit was determined by standard
curves generated with 10-fold serial dilutions (107–10) of SaV GII
standard plasmid, and 100 copies/L GII corresponded to a cycle
threshold (Ct) value of 38. Therefore, a sample with a Ct value <38
was considered to be positive for SaV. Three positive and one neg-
ative controls were included to conﬁrm the expected Ct values.
Samples were tested for norovirus group II with the primer pair
COG2FandG2SKRbyconventional PCR. For rotavirus, sampleswere
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Fig. 1. Sapovirus detected in hospitalized children aged less than 5 years with acute gastroenteritis by age.
The children with acute gastroenteritis from which stool samples were obtained were divided into ﬁve age groups, and the number of tested samples (cases) in each age
group is shown. The black bars and grey bars indicate the SaV-positive and SaV-negative cases, respectively. The numbers above bars are the number of SaV-positive cases
and the percentage of SaV-positive cases among the total cases in each age group (in parentheses).
tested by the glycoprotein and protease-susceptible protein geno-
typing methods using conventional PCR [20].
3.3. SaV genotyping and nucleotide sequencing
SaV-positive samples were genotyped by nested PCR targeting
the partial capsid region [21] and by conventional PCR targeting
the polymerase region. For samples in which different SaV geno-
types were identiﬁed for the capsid and polymerase regions, a long
gene segment covering both the capsid and polymerase regions
was ampliﬁed with region speciﬁc primer pairs (Table 1). These
long PCR products were TA cloned into the pGEM-T easy vector
(Promega, Madison, Wisconsin, USA) to check for the possibil-
ity of co-infection with different SaV strains. To determine the
recombination points, additional primers were designed, and four
overlapping segments were ampliﬁed to cover the full genome
of the recombinant strains (Supplementary Fig. 2). All PCR prod-
ucts were puriﬁed with the QIAquick PCR puriﬁcation kit (Qiagen),
sequenced using BigDye Terminator version 1.1 (Life Technolo-
gies), and analyzed using an Applied Biosystems 3700 Genetic
Analyzer (Life Technologies). The primers used for SaV are shown
in Table 1. The SaV sequences obtained in this studywere deposited
in GenBank under accession numbers KP067397–KP067418 for
the polymerase sequences, KP067419–KP067443 for the capsid
sequences, and KP067444 for the full genome sequence.
Supplementrymaterial related to this article found, in theonline
version, at http://dx.doi.org/10.1016/j.jcv.2015.05.001
3.4. Sequence analysis and recombination analysis
The sequence data were aligned with ClustalW, and phylo-
genetic trees were constructed by the neighbor-joining method
with the Kimura 2 parameter settings using the MEGA 5 soft-
ware package. The closest sequence available in GenBank and
the sequence similarity between analyzed samples and reference
sequencesweredeterminedusing theBasic Local Alignment Search
Tool (http://blast.ncbi.nlm.nih.gov/Blast.cgi). Possible recombina-
tion and the conﬁdence value of recombination between the
suspected recombinant and parent strainswere examined by RDP4
[22]. The genetic similarity between the recombinant and putative
parent strains was plotted with SimPlot [23].
4. Results
4.1. Prevalence of SaV
A total of 417 stool samples (from 166 males and 251 females)
were tested for SaV, astrovirus, rotavirus, and norovirus genogroup
II. The overall detection rate of SaV was 7.0% (29/417): 7.0% in
EVRMC (18/257), 7.8% in ONP (8/103), and 5.3% in PCMC (3/57).
The age distribution of tested cases and SaV-positive cases are
shown in Fig. 1. The median and mean age of the tested cases
were 12.0 (interquartile range, 7.5–19.0) months and 14.7 months,
respectively. The highest proportion of SaV-positive samples was
observed in children aged 18–23 months. There was no signiﬁcant
difference in the detection rate between male and female (6.4% vs.
7.8%, p=0.56). For the other three viruses, rotavirus was the most
common virus identiﬁed (50.6%, 211/417), followed by norovirus
genogroup II (6.0%, 25/417), and astrovirus (4.1%, 17/417). Among
the 29 SaV-positive cases, 10 were also positive for other viral
pathogens, including rotavirus (n=6), norovirus (n=2), and astro-
virus (n=2). ThemedianCt valueswere lower in the cases thatwere
SaV positive only than in those with co-infection, although it was
not statistically signiﬁcant (29.9 vs. 33.2, p=0.55).
4.2. Molecular characterization of SaV and phylogenic analysis
The partial capsid gene sequence (364-nucleotides [nt]) was
determined for 26 of the 29 SaV-positive samples because three
samples were not sequenced due to suboptimal ampliﬁcation by
PCR. Five different genotypeswere identiﬁed:GI.1 (7), GI.2 (2), GII.1
(12), GII.4 (3), and GV (2). Of the 12 SaV GII.1 strains, 11 were clus-
tered with the GII.1 Bristol/98/UK strain in the phylogenetic tree
(Fig. 2a) and showed 96–98% nt homology to this prototype strain.
All GI.1 strains from this study showed 99% nt homology to the
Manchester strain (X86560). Three GII.4 strains shared the highest
similarity (91–92%)with theGII.4 Kumamoto6/Mar2003/JPN strain
(AB429084). Two GI.2 strains were observed in the late phase of
the study period (July 2013), and shared 99% nt homology with the
emerging GI.2 strains.
A secondphylogenetic treewas constructed based on the partial
polymerase gene (463 nt; Fig. 2b). All strains, except for three GII.4
strains, were clustered into the concordant genotypes assigned by
the capsid gene sequences. In contrast, all three GII.4 strains, which
shared 99% nt homology, were clustered into SaV GII.1 and were
distant from theGII.4 Kumamoto6/Mar2003/JPN strain. Thus, these
three strains were suspected to be GII.1/GII.4 recombinants. Two
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Fig. 2. Phylogenetic analysis of the sapovirus capsid gene (364 nt, a) and the polymerase gene (463 nt, b).
The phylogenetic trees were inferred by the neighbor-joining method (Kimura 2-parameter model) using MEGA5. The trees are drawn to scale, with branch lengths repre-
senting the number of base substitutions per site. The bootstrap value (≥80%) is shown next to the branches. Strains from EVRMC, ONP, and PCMC are marked with , , and
, respectively. The recombinant strains are shown as thick branches in both trees.
Fig. 3. TGO12-028 was plotted against the complete genome sequence of Bristol/98/UK and the 3′ terminal region (4523–7460 nt) of GII.4 Kumamoto6/Mar2003/JPN.
The x-axis indicates the nucleotide position of TGO12-028 and the y-axis shows the similarity between the query strain and reference strains. The vertical dotted line indicates
the recombination breakpoint.
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of these three strains were detected at EVRMC on Leyte Island in
July and August 2012 and one was detected from a patient at ONP
on Palawan Island in September 2012. In one of these three cases,
rotavirus was also detected.
4.3. Recombination analysis
Since the partial polymerase and capsid sequences of the three
suspected recombinant samples shared 99% similarity, we selected
two samples: TGO12-028 from ONP on Palawan Island and TGE12-
029 from EVRMC on Leyte Island to rule out the possibility that
detection of different genotypes in the polymerase and capsid
regions was due to mixed-infection with different SaV strains.
Sequencing of multiple clones carrying the partial polymerase
and capsid (954 nt) regions showed that only GII.1 and G.II4
sequences were detected in polymerase and capsid gene clones,
respectively. The full genome of SaV from TGO12-028 was fur-
ther characterized [7460 nt, excluding the poly (A) tail of ORF1
(14–6853 nt) and ORF2 (6853–7353 nt)]. TGO12-028 shared the
highest similarity (94% at the nt level and 99% at the amino
acid level) with GII.1 Bristol/98/UK in the nonstructural protein
region (14–5173 nt). However, in the structural protein region
(5174–7353 nt) the similarity between them was only 74% at
the nt level and 83% at the amino acid level. In contrast, TGO12-
028 showed the highest similarity (92% at the nt level and 99%
at the amino acid level) to GII.4 Kumamoto6/Mar2003/JPN in the
structural protein region, and lower nucleotide similarity (85%) in
the partial polymerase region (4523–5173 nt). These results indi-
cate that TGO12-028 is a recombinant virus containing a portion
of a Bristol/98/UK-like virus and a Kumamoto6/Mar2003/JPN-like
virus. A recombination point for TGO12-028was identiﬁed at posi-
tion 5166 (p=7.44×10−29) by RDP4. Since the longest SaV GII.4
sequence available in GenBank is Kumamoto6/Mar2003/JPN (total
length, 2982 nt; covering the 3′ end of the polymerase, the entire
structural protein region, and the 3′ NTR), TGO12-028 was plotted
against the full genome sequence of GII.1 Bristol/98/UK and the 3′
terminus of GII.4 Kumamoto6/Mar2003/JPN (4523–7460 nt, Fig. 3).
5. Discussion and conclusion
Using a sensitive PCR assay, SaV was recently deﬁned as the
second major viral cause of acute gastroenteritis after norovirus
in a large-scale population-based study of all age groups in UK in
2008–2009 [24]. Thedetection rates for SaVhave recently increased
to 8.8–17% in several countries [11,25]. Since reports of SaV out-
breaks across all age groups have been increasingworldwide, a SaV
diagnostic assay is recommended for use during viral gastroenteri-
tis outbreaks [4]. Notably, SaV togetherwithnorovirusmaybecome
themajor causative agentsof viral acutegastroenteritis amongchil-
dren in countries that implement national rotavirus vaccination, as
hasbeenshown inNicaragua [25]. In this study,we investigatedSaV
in the Philippines for the ﬁrst time. The overall SaV-positive rate
(7.0%) was higher than that in similar studies (0–5%) of hospital-
ized children with gastroenteritis in Thailand [26], Japan, Denmark
[11], the USA [3], and Australia [27]. The higher detection rate of
sapovirus in this study was not because of rotavirus vaccination
since only two patients (2/419, 0.5%) in this study had received
rotavirus vaccines. A possible explanation for the higher SaV detec-
tion rate in this study couldbe theuseof real-timePCR targeting the
conserved region at the junction between polymerase and capsid
genes, which can amplify multiple genogroups of SaV [19]. Other
studies used single round PCR [3,11,26,27], which targeted rela-
tively diverse regions of polymerase or capsid and failed to amplify
several variant genotypes. A study showed that real-time PCRwith
similar primers and probes as we used in this study had 10-fold
higher sensitivity than the single round PCR [28]. In addition, the
higher occurrence of SaV in this study could be due to seasonal
ﬂuctuation. We found that approximately 30% of the SaV-positive
cases were also positive for other gastroenteric viruses. However,
in this study, we could not compare the severity or clinical mani-
festations between SaV-positive only and co-infection cases since
detailed information on clinical symptoms was not recorded. Dur-
ing the study period (2012–2013), SaV GII.1 was most commonly
detected in this study, whereas GI.2 was a dominant genotype dur-
ing the same period in neighboring countries, including Japan and
China [29].
To date, three types of SaV recombinants have been described:
inter-genogroup (e.g., GII/GIV) [15], inter-genotype (e.g., GI.1/GI.2
and GII.2/GII.3) [30], and intra-genotype (e.g., GI.1b/GI.1a) [31]
strains. Among these recombinant strains, GII/GIV has caused sev-
eral outbreaks in Japan, USA, and Canada between 2006 and 2009,
and it continues to cause sporadic cases in several other countries
[13,17,32]. In this study, we identiﬁed another novel inter-
genotype recombinant, GII.1/GII.4. The putative recombination
breakpoint was located at the junction between the polymerase
and capsid, where the majority of recombinant points have been
identiﬁed for both SaV and norovirus [33]. The junction between
the polymerase and capsid on the antisense strand of calicivirus
is predicted to have conserved subgenomic RNA promoters and
stem-loop structures, which could facilitate the exchange of tem-
plates during virus replication [33,34]. A review of the sequence
database showed that GII.1 strains have been commonly detected
in other countries as well as in this study, whereas, GII.4 strains
have only been detected in Pakistan (1992), Japan (2003 and 2008),
Vietnam (2006), UK (2008), Brazil (2010), and Kenya (2014). The
GII.1/GII.4 recombinant may have emerged as a result of a com-
monly circulatingGII.1 strain capturing the capsid of anuncommon
GII.4 strain within a host who was simultaneously infected with
both strains. We assumed that multiple synonymous substitutions
occurred in this novel recombinant after recombination because
therewas only 92% or 94% nt similarity but 99% amino acid similar-
ity between the recombinant anddonor segments of the circulating
tentative parent strains (GII.1 or GII.4). By acquiring a new capsid
gene, inter-genotype recombinants display different antigenici-
ties [16]; therefore, they may escape from herd immunity and
cause outbreaks, as suggested by SaV GII/GIV and GII.2/GII.3 [17].
SaV GII.1/GII.4 recombinant strains were detected in two distant
islands in the Philippines, i.e., Leyte and Palawan Islands, which
suggest that these recombinant strains were widely circulating in
the Philippines. Therefore, continuous monitoring is required to
reveal the signiﬁcance of this novel recombinant.
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